Ivor Royston - 29 Dec 2021 Form 4 Insider Report for Viracta Therapeutics, Inc. (VIRX)

Signature
/s/ Michael Mueller, as Attorney-in-Fact
Issuer symbol
VIRX
Transactions as of
29 Dec 2021
Net transactions value
+$6,300
Form type
4
Filing time
30 Dec 2021, 17:47:58 UTC
Previous filing
29 Nov 2021
Next filing
01 Mar 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VIRX Common Stock Options Exercise $6,300 +7,000 +1.2% $0.9000 578,289 29 Dec 2021 Direct
holding VIRX Common Stock 18,599 29 Dec 2021 By spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VIRX Stock Option (Right to Buy) Options Exercise $0 -7,000 -10% $0.000000 60,800 29 Dec 2021 Common Stock 7,000 $0.9000 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One forty-eighth (1/48th) of the Shares subject to the Option shall vest on the one (1) month anniversary of February 13, 2019 (the "Vesting Commencement Date"), and one forty-eighth (1/48th) of the Shares subject to the Option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month), subject to the reporting person continuing to be a Service Provider in accordance with the Plan through each such date.